A real world study to evaluate risk of common infections in secukinumab users compared to ustekinumab users among individuals with psoriasis in Sweden-A population register cohort based study
Latest Information Update: 01 Oct 2020
At a glance
- Drugs Secukinumab (Primary) ; Ustekinumab (Primary)
- Indications Psoriasis; Psoriatic arthritis
- Focus Adverse reactions
- 30 Sep 2020 New trial record
- 25 Sep 2020 Results published in the Pharmacoepidemiology and Drug Safety